IMVIONIX Trademark

Trademark Overview

On Wednesday, April 2, 2025, a trademark application was filed for IMVIONIX with the United States Patent and Trademark Office. The USPTO has given the IMVIONIX trademark a serial number of 99116394. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 2, 2025. This trademark is owned by Imvionix Inc.. The IMVIONIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development and commercialization of products in the field of ophthalmology; research, development and commercialization of products in the field of healthcare
imvionix

General Information

Serial Number99116394
Word MarkIMVIONIX
Filing DateWednesday, April 2, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch, development and commercialization of products in the field of ophthalmology; research, development and commercialization of products in the field of healthcare

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImvionix Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJohns Creek, GA 30097

Trademark Events

Event DateEvent Description
Wednesday, April 2, 2025NEW APPLICATION ENTERED
Wednesday, April 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, April 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

imvionix field research products commercialization development healthcare ophthalmology